Commentary · 21 Feb 2026
Conference abstractPublished 21 Oct 2013
Preclinical and clinical testing of a alpha-ketoglutarate/5-HMF/N-actyl-selenomethionine and N-acteyl-methionine for treating tumors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This lecture will address of the use of a newly developed therapeutic substance combination (KARAL®) namely alpha-ketoglutarate (AKG)/5-Hydroxymethylfurfurale (5-HMF)/N-Acetyl-Selenomethionine (NASeLM) and N-Acteyl-methionine (NALM). Supplementation of of AKG/5-HMF alone (Sanopal®, CYL-Phamraceutica) was used in a clinical study as pre-operative solution in patients with lung cancer. Results showed significant reduction of complications during surgery, massive better conditions before and after surgery (reduction of hospitalization +/- 11 days) compared to control group. Single substances, and combination of all substances in several concentrations showed on cancer cells (Jurkat, non-small cancer cells, thyroid cancer cells, prostate cancer cells) concentration dependent decrease of mitochondrial activity, cell growth and an increase of caspase-3 activity. In two pre-clinical studies (cancer in lung, pleura and esophagus and prostate cancer) on the Medical University of Graz and on the Medical University of Vienna promising results ratify the outcomes of cell studies.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Joachim Greilberger”
